Next Article in Journal
Protection and Safety Evaluation of Live Constructions Derived from the Pgm and pPCP1 Yersinia pestis Strain
Previous Article in Journal
Clinical Challenges in a 49-Year-Old Patient with Severe Tick-Borne Myeloradiculitis Despite Complete Active Vaccination
Previous Article in Special Issue
Yellow Fever Virus Genotyping Tool and Investigation of Suspected Adverse Events Following Yellow Fever Vaccination
 
 
Correction
Peer-Review Record

Correction: Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection. Vaccines 2019, 7, 72

by Gustavo Cabral-Miranda 1,2,*, Stephanie M. Lim 3, Mona O. Mohsen 1,2, Ilya V. Pobelov 4, Elisa S. Roesti 2, Matthew D. Heath 5, Murray A. Skinner 5, Matthias F. Kramer 5, Byron E. E. Martina 3,6 and Martin F. Bachmann 1,2,*
Submission received: 13 February 2020 / Accepted: 19 February 2020 / Published: 20 February 2020
Back to TopTop